|
SIX4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.857000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.090200E-02 |
| Normal-vs-Stage2 |
6.981400E-01 |
| Normal-vs-Stage3 |
1.828420E-02 |
| Normal-vs-Stage4 |
9.182100E-02 |
| Stage1-vs-Stage2 |
4.084000E-01 |
| Stage1-vs-Stage3 |
2.106400E-01 |
| Stage1-vs-Stage4 |
4.555200E-01 |
| Stage2-vs-Stage3 |
8.718000E-02 |
| Stage2-vs-Stage4 |
2.146000E-01 |
| Stage3-vs-Stage4 |
8.072000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.755190E-03 |
| Normal-vs-AfricanAmerican |
1.024560E-01 |
| Normal-vs-Asian |
3.637400E-01 |
| Caucasian-vs-AfricanAmerican |
5.846200E-01 |
| Caucasian-vs-Asian |
1.856140E-03 |
| AfricanAmerican-vs-Asian |
5.181600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.412040E-02 |
| Normal-vs-Female |
2.194200E-02 |
| Male-vs-Female |
4.331000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.485600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.060000E-02 |
| Normal-vs-Age(61-80Yrs) |
6.496200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.268100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.601600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.017400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.171000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.490800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.291750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.381900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.472400E-01 |
| Classical-VS-Follicular |
3.164200E-02 |
| Classical-VS-Other |
9.041600E-01 |
| Classical-VS-Normal |
7.575000E-04 |
| Tall-VS-Follicular |
1.985030E-01 |
| Tall-VS-Other |
8.657400E-01 |
| Tall-VS-Normal |
1.587780E-01 |
| Follicular-VS-Other |
5.923400E-01 |
| Follicular-VS-Normal |
9.118800E-01 |
| Other-VS-Normal |
5.905000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.047600E-01 |
| Normal-vs-N1 |
1.483990E-01 |
| N0-vs-N1 |
4.913800E-01 |
|
|
